Skip to main content

Table 1 Patient/sample characteristics with known ARID1A mutation status according to histotype

From: A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

  Clear cell Endometrioid Serous
Characteristic No. (%) No. (%) No. (%)
  Stage    
  1/2 19 (61) 21 (88) 6 (17)
  3/4 11 (35) 2 (8) 29 (83)
  Missing 1 (3) 1 (3)  
ARID1A mutation    
  No 14 (45) 19 (79) 35 (100)
  Yes 17 (55) 5 (21) 0 (0)
PIK3CA mutation    
  None 17 (55) 13 (54) NT
  Helical 7 (23) 4 (17) NT
  Kinase 4 (13) 4 (17) NT
  Other 3 (9) 3 (12) NT
  1. NT = not tested.